1.165
price down icon0.85%   -0.005
 
loading

Finanzdaten der Hyperfine Inc-Aktie (HYPR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
3.437
- 2.137 2.321 3.643
Cost Of Revenue
1.589
- 1.254 1.495 1.735
Gross Profit
1.848
- 0.883 0.826 1.908
Operating Expenses
10.77
- 11.79 11.59 12.87
Benefits Costs and Expenses
14.46
- 11.55 12.71 13.97
Costs And Expenses
14.46
- 11.55 12.71 13.97
Operating Income/Loss
-8.92
- -10.90 -10.77 -10.96
Income/Loss From Continuing Operations Before Tax
19.45%
-11.02
-9.225 -9.418 -10.39 -10.33
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.45%
-11.02
-9.225 -9.418 -10.39 -10.33
Net Income/Loss
19.45%
-11.02
-9.225 -9.418 -10.39 -10.33
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
79.03
- 75.70 0.1939 72.68
Diluted Average Shares
79.03
- 75.70 0.1939 72.68
Basic Earnings Per Share
-0.14
- -0.12 -0.14 -0.14
Diluted Earnings Per Share
-0.14
- -0.12 -0.14 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
medical_devices ZBH
$93.24
price up icon 0.70%
medical_devices STE
$214.64
price up icon 1.34%
$64.99
price down icon 0.75%
medical_devices PHG
$27.77
price down icon 1.68%
$70.74
price up icon 0.64%
medical_devices EW
$81.75
price down icon 3.34%
Kapitalisierung:     |  Volumen (24h):